Human NaV1.7 (SCN9A) (extracellular) Blocking Peptide (#BLP-SC029) is the original antigen used for immunization during Anti-Human NaV1.7 (SCN9A) (extracellular) Antibody (#ASC-029) generation. The blocking peptide binds and ‘blocks’ Anti-Human NaV1.7 (SCN9A) (extracellular) primary antibody, this makes it a good negative reagent control to help confirm antibody specificity in western blot and immunohistochemistry applications. This control is also often called a pre-adsorption control.